Home/Filings/4/0001104659-24-043156
4//SEC Filing

SAPIRSTEIN JAMES 4

Accession 0001104659-24-043156

CIK 0001604191other

Filed

Apr 2, 8:00 PM ET

Accepted

Apr 3, 5:14 PM ET

Size

5.4 KB

Accession

0001104659-24-043156

Insider Transaction Report

Form 4
Period: 2024-04-01
SAPIRSTEIN JAMES
DirectorPRESIDENT AND CEO
Transactions
  • Sale

    Common Stock

    2024-04-01$4.23/sh174$73637,105 total
Footnotes (2)
  • [F1]The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
  • [F2]Includes unvested RSUs.

Issuer

First Wave BioPharma, Inc.

CIK 0001604191

Entity typeother

Related Parties

1
  • filerCIK 0001559509

Filing Metadata

Form type
4
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 5:14 PM ET
Size
5.4 KB